Pharmacokinetics and feeding responses to muramyl dipeptide in rats

Physiology and Behavior

Volumn 79, Issue 2, 2003, Pages 173-182

  Fosset, Sophie ^a,b   Fromentin, Gilles ^a   Rampin, Olivier ^c   Lang, Vincent ^b   Mathieu, Florence ^b   Tomé, Daniel ^a  

^a AGROPARISTECH   (France)

^b DANONE RESEARCH   (France)

^c CEMAGREF   (France)

Author keywords

Anorexia; Behavioral satiety sequence; Conditioned food aversion; Food intake; Meal pattern; Muramyl dipeptide; Pharmacokinetics

Indexed keywords

MURAMYL DIPEPTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; AVERSION; CONTROLLED STUDY; FEEDING BEHAVIOR; FOOD INTAKE; GASTROINTESTINAL ABSORPTION; HYPOPHAGIA; MALE; MEAL; NONHUMAN; PRIORITY JOURNAL; RAT; SATIETY; SYSTEMIC CIRCULATION;

EID: 0038481993     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(03)00065-9     Document Type: Article

References (54)

1. Damais C., Riveau S., Parant M., Gerota J., Chedid L. Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyldipeptide derivative. Int. J. Immunopharmacol. 4:1982;451-462.
2. Sen Z., Karnovsky M.L. Qualitative detection of muramic acid in normal mammalian tissues. Infect. Immun. 43:1984;937-941.
3. Karnovsky M.L. Muramyl peptides in mammalian tissues and their effects at the cellular level. Fed. Proc. 45:1986;2556-2560.
4. Krueger J.M., Majde J.A. Microbial products and cytokines in sleep and fever regulation. Crit. Rev. Immunol. 14(3-4):1994;355-379.
5. Johannsen L., Wecke J., Obal F. Jr., Krueger J.M. Macrophages produce somnogenic and pyrogenic muramyl peptides during digestion of staphylococci. Am. J. Physiol. 260(1 Pt. 2):1991;R126-R133.
6. Langhans W. Bacterial products and the control of ingestive behavior: clinical implications. Nutrition. 12:1996;303-315.
7. Sriskandan S., Cohen J. Gram-positive sepsis. Mechanisms and differences from Gram-negative sepsis. Infect. Dis. Clin. North Am. 13:1999;397-412.
8. Weingarten S., Senn M., Langhans W. Does a learned taste aversion contribute to anorectic effect of bacterial lipopolysaccharide? Physiol. Behav. 54:1993;961-966.
9. Plata-Salaman C.R. Anorexia during acute and chronic disease. Nutrition. 12(2):1996;69-78.
10. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12:1988;123-137.
11. Hart B.L. Behavioral adaptations to pathogens and parasites: five strategies. Neurosci. Biobehav. Rev. 14:1990;273-294.
12. Plata-Salaman C.R. Immunoregulators in the nervous system. Neurosci. Biobehav. Rev. 15(2):1991;185-215.
13. Weingarten H.P. Cytokines and food intake: the relevance of the immune system to the student of ingestive behavior. Neurosci. Biobehav. Rev. 20(1):1996;163-170.
14. Plata-Salaman C.R. Cytokine-induced anorexia. Behavioral, cellular, and molecular mechanisms. Ann. N.Y. Acad. Sci. 856:1998;160-170.
15. Langhans W., Hrupka B. Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides. 33(5):1999;415-424.
16. Silverman D.H.S., Krueger J.K., Karnovsky M.L. Specific binding sites for muramyl peptides on murine macrophages. J. Immunol. 136:1986;2195-2201.
17. Dziarski R. Binding sites for peptidoglycan on mouse lymphocytes. Cell. Immunol. 109:1987;231-245.
18. Dziarski R. Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking. J. Biol. Chem. 266:1991;4713-4718.
19. Halford J.C.G., Blundell J.E. The 5-HT1B agonist CP-94,253 reduces food intake and preserves the behavioral satiety sequence. Physiol. Behav. 60:1996;933-939.
20. Halford J.C.G., Blundell J.E. Further analysis of drug effects on the behavioral sequence associated with satiety. J. Psychopharmacol. (Suppl. 7):1998;A34-A66.
21. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76 Rodent Diet. J. Nutr. 123:1993;1939-1951.
22. Nicolaïdis S., Rowland N., Meile M.J., Marfaing-Jallat P., Pesez A. A flexible technique for long term infusions in unrestrained rats. Pharmacol. Biochem. Behav. 2:1974;131-136.
23. Steffens A.B. A method for frequent sampling of blood and continuous infusion of fluids in the rat without disturbing the animal. Physiol. Behav. 4:1969;833-836.
24. Castonguay T.W., Kaiser L.L., Stern J.S. Meal pattern analysis: artifacts, assumptions and implications. Brain. Res. Bull. 17(3):1986;439-443.
25. Antin J., Gibbs J., Holt J., Young R.C., Smith G.P. Cholecystokinin elicits the complete behavioural sequence of satiety in rats. J. Comp. Physiol. Psychol. 89:1975;760-784.
26. Kirkham T.C., Blundell J.E. Dual action of naloxone on feeding revealed by behavioural analysis: separate effects on initiation and termination of eating. Appetite. 5(1):1984;45-52.
27. Halford J.C.G., Wanninayake S.C.D., Blundell J.E. Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol. Biochem. Behav. 61(2):1998;159-168.
28. Adibi S.A. The oligopeptide transporter (Pept-1) in human intestine: biology and function. Gastroenterology. 113(1):1997;332-340.
29. Gardner M.L., Wood D. Transport of peptides across the gastrointestinal tract. Biochem. Soc. Trans. 17(5):1989;934-937.
30. Valinger Z., Ladesic B., Hrsak I., Tomasic J. Relationship of metabolism and immunostimulating activity of peptidoglycan monomer in mice after three different routes of administration. Int. J. Immunopharmacol. 9(3):1987;325-332.
31. Harrison J., Fox A. Degradation of muramyl dipeptide by mammalian serum. Infect. Immun. 57:1985;2726-2732.
32. 14C-labelled immunoadjuvant peptidoglycan monomer: II. In vitro studies. Biochim. Biophys. Acta. 678:1981;12-17.
33. Mollner S., Braun V. Murein hydrolase (N-acetyl muramyl-L-alanine amidase) in human serum. Arch. Microbiol. 140:1984;171-177.
34. Biberstine K.J., Rosenthal R.S. Peptidoglycan fragments decrease food intake and body weight gain in rats. Infect. Immun. 62(8):1994;3276-3281.
35. Ambler L., Hudson A.M. Pharmacokinetics and metabolism of muramyl dipeptide and nor-muramyl dipeptide [3H-labelled] in the mouse. Int. J. Immunopharmacol. 6(2):1984;133-139.
36. 14C-labelled) in the mouse. Int. J. Immunopharmacol. 1:1979;35-41.
37. Langhans W., Harlacher R., Balkowski G., Sharrer E. Comparison of the effects of bacterial lipopolysaccharide and muramyl dipeptide on food intake. Physiol. Behav. 47:1990;805-813.
38. Langhans W., Balkowski G., Savoldelli D. Differential feeding responses to bacterial lipopolysaccharide and muramyl dipeptide. Am. J. Physiol. 261:1991;R659-R664.
39. Movat H.Z., Cybulsky M.I., Colditz I.G., Chan M.K.W., Dinarello C.A. Acute inflammation in Gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed. Proc. 46:1987;97-104.
40. Gayle D., Ilyin S.E., Flynn M.C., Plata-Salaman C.R. Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropetide systems mRNAs. Brain Res. 795:1998;77-86.
41. Porter M.H., Hrupka B.J., Langhans W., Schwartz G.J. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1β, LPS and MDP. Am. J. Physiol. 275:1998;R384-R389.
42. Auci D.L., Kleiner G.I., Chice S.M., Athanassiades T.J., Dukor P., Durkin H.G. Control of IgE responses: V. Oral administration of a synthetic derivative of the inner bacterial cell wall (SDZ 280.636) to sensitized mice induces isotype specific suppression of peak hapten specific IgE antibody forming cell responses, serum IgE levels and immediate hypersensitivity responses. Immunol. Invest. 27(1-2):1998;105-120.
43. Plata-Salaman C.R. Cytokines and feeding. Int. J. Obes. Relat. Metab. Disord. 25(Suppl. 5):2001;S48-S52.
44. Smith G.P., Gibbs J. Postprandial satiety. Prog. Psychobiol. Physiol. Psychol. 8:1979;179-242.
45. VanderWeele D.A., Granja J.A., Deems D.A. Discomfort or satiety: the spontaneous meal pattern may serve as a predictor. Hoebel B.G., Novin D. The neural basis of feeding and reward. 1982;167-173 Haer Institute Press, Brunswick, ME.
46. Blundell J.E., Rogers P.J., Hill A.J. Behavioural structure and mechanisms of anorexia: calibration of natural and abnormal inhibition of eating. Brain. Res. Bull. 15(4):1985;371-376.
47. Dourish C.T., Rycroft W., Iverson S.D. Postponement of satiety by blockage of brain cholecystokinin (CCK-B) receptors. Science. 245:1989;1509-1511.
48. Simansky K.J., Vaidya A.H. Behavioural mechanisms for the anorectic actions of the serotonin (5-HT) uptake inhibitor setraline in rats: comparison with directly acting agonists. Brain. Res. Bull. 25:1990;953-960.
49. 2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology. 113:1994;369-377.
50. Le Magnen J. Neurobiology of feeding and nutrition. 1992;Academic Press, Londres.
51. Cooper S.J., Francis J. A microstructural analysis of the effects of presatiation behavior in the rat. Physiol. Behav. 53(2):1993;413-416.
52. Nachman M. Learned aversion to the taste of lithium chloride and generalization to the other salts. J. Comp. Physiol. Psychol. 56:1963;343-349.
53. Dess N.K., Vanderweele D.A. Lithium chloride and inescapable, unsignaled tail shock differentially affect meal patterns of rats. Physiol. Behav. 56(1):1994;203-207.
54. Feurte S., Nicolaidis S., Berridge K.C. Conditioned taste aversion in rats for a threonine deficient diet: demonstration by the taste reactivity test. Physiol. Behav. 68(3):2000;423-429.